Reuters According to a recent Stanford University study, the plant-based psychoactive drug Ibogaine, when combined with magnesium to protect the heart, safely and effectively reduces post-traumatic stress disorder (PTSD), anxiety, and depression by over 80% and improves functioning and well-being in veterans with traumatic brain injuries — Ibogaine is also effective in combating opioid addiction.
Ibogaine is a naturally occurring compound found in the roots of the Gabonese shrub Tabernanthe iboga that Gabonese members of the Bwiti religion have used for centuries in spiritual and healing ceremonies. A 2021 article in Time Magazine stated that psychedelics like Ibogaine are rapidly approaching acceptance in mainstream medicine, and that the plant is one of the most promising psychedelics for defeating addiction.
While Ibogaine treatment has mushroomed in Mexico and a few other nations, in the U.S. Ibogaine remains on the Schedule I list of controlled substances. The official government line is that Ibogaine has no recognized medical benefits and has a high risk of abuse.
While Ibogaine’s status in the U.S. may one day be reviewed, Ibogaine is legal or unregulated in Australia, New Zealand, Costa Rica, Mexico, Jamaica, and the Netherlands – Indeed hundreds of facilities offer Ibogaine therapy worldwide.
Meanwhile however, millions of Americans continue to suffer as the U.S. government and the pharmaceutical industry ignore (or suppress) Ibogaine therapy.
According to Martin Shefsky, whose company, mPath Therapeutics, is manufacturing Pharmaceutical grade GMP Certified Ibogaine in Jamaica, the success rate of the nation’s 17,000-plus PTSD and opioid treatment centers is extremely low.
Shefsky says the staggering amount of money spent by America’s Veterans Administration, in addition to other government agencies and individuals, could be dramatically cut by legalizing Ibogaine treatment in the U.S.
According to Ibogaine co-pioneer Boaz Wachtel, both the U.S. Army and a Dutch national committee have presented data demonstrating that two-thirds of PTSD sufferers are not being helped by current behavioral or pharmaceutical treatments. Switching to Ibogaine, he believes, could save huge sums of money and enable multitudes to lead more productive lives.
To combat the spread of the opioid epidemic, the U.S. Congress has allocated $10.6 billion, mostly through the SUPPORT for Patients […]
If Approved, A Gabonese Plant Brings Hope For PTSD, Opioid Sufferers
